Objectives: The drug K201 (JTV-519) increases inotropy and suppresses arrhythmias in failing hearts, but the effects of K201 on normal hearts is unknown. Methods: The effect of K201 on excitation-contraction (E-C) coupling in normal myocardium was studied by using voltage-clamp and intracellular Ca 2+ measurements in intact cells. Sarcoplasmic reticulum (SR) function was assessed using permeabilised cardiomyocytes. Results: Acute application of b1 μmol/L K201 had no significant effect on E-C coupling. K201 at 1 μmol/L decreased Ca 2+ transient amplitude (to 83 ± 7%) without affecting I Ca,L or the SR Ca 2+ content. At 3 μmol/L K201 caused a larger reduction of Ca 2+ transient amplitude (to 60 ± 7%) with accompanying reductions in I Ca,L amplitude (to 66 ± 8%) and SR Ca 2+ content (74 ± 9%). Spontaneous SR Ca 2+ release during diastole was induced by increasing intracellular [Ca 2+ ]. At 1 μmol/L K201 reduced the frequency of spontaneous Ca 2+ release. The effect of K201 on SR-mediated Ca 2+ waves and Ca 2+ sparks was examined in β-escin-permeabilised cardiomyocytes by confocal microscopy. K201 (1 μmol/L) reduced the frequency and velocity of SR Ca 2+ waves despite no change in SR Ca 2+ content. At 3 μmol/L K201 completely abolished Ca 2+ waves and reduced the SR Ca 2+ content (to ∼ 73%). K201 at 1 μmol/L reduced Ca 2+ spark amplitude and frequency. Assays specific to SR Ca 2+ -ATPase and RyR2 activity indicated that K201 inhibited both SR Ca 2+ uptake and release. Conclusions: K201 modifies E-C coupling in normal cardiomyocytes. A dual inhibitory action on SERCA and RyR2 explains the ability of K201 to suppress spontaneous diastolic Ca 2+ release during Ca 2+ overload without significantly affecting Ca 2+ transient amplitude.
Introduction
The drug K201 (JTV-519) is a 1,4 benzothiazepine derivative which was found to be more effective than other Ca 2+ channel antagonists at reducing Ca 2+ -induced myocardial damage [1] . While the drug is known to have multiple sites of action in the heart, recent work suggests that the beneficial effect of K201 during heart failure (HF) is mediated by actions on the ryanodine receptor (RyR2) complex [2, 3] . In HF, abnormal function of RyR2 is thought to result in excessive diastolic Ca 2+ release contributing to (a) impaired contractile function and (b) increased incidence of arrhythmias [3] . One theory for abnormal RyR2 function centres on the loss of an RyR2 accessory protein (FK-506 binding protein -FKBP12.6) [4] . A second related possibility is reduced RyR2 inter-domain interaction [5] . Previous studies suggest that K201: (a) restores the binding of FKBP12.6 to RyR2 [3] and/or (b) restores RyR2 inter-domain interaction [5] . To date, the effect of K201 on E-C coupling has only been examined in HF models or after disruption of RyR2-FKBP12. 6 interaction.
This study is the first to investigate the effect of K201 on E-C coupling in cardiomyocytes isolated from normal hearts. Using both electrophysiology and confocal imaging, we demonstrate that K201 (1 μmol/L) reduces Ca 2+ transient amplitude in normal rabbit cardiomocytes without changing L-type Ca 2+ transient amplitude or SR Ca 2+ content. When cardiomyocytes in Ca 2+ overload were exposed to K201, the incidence of spontaneous diastolic SR Ca 2+ release was reduced but the amplitude of the Ca 2+ transient was unchanged. These actions of K201 are explained in terms of inhibitory effects on RyR2 and SR Ca 2+ -ATPase (SERCA).
Materials and methods

Ventricular cardiomyocyte isolation
New Zealand White rabbits (2-2.5 kg) were euthanised by administration of an intravenous injection of 500 IU heparin together with an overdose of sodium pentobarbitone (100 mg kg − 1 ). Hearts were removed in accordance with the United Kingdom Animals (Scientific Procedures) Act 1986, and conformed to the Guide for the Care and use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1985) . Rabbit ventricular cardiomyocytes were then isolated as previously described [6] .
Electrophysiological measurements in rabbit cardiomyocytes
The isolated cardiomyocytes were superfused with a Krebs Hensliet solution (mmol/L): 144 NaCl, 5.4 KCl, 1.0 MgCl 2 , 5.0 HEPES, 11.1 Glucose, 0.3 NaH 2 PO 4 ·2H 2 0, 1.8 CaCl 2 , 0.1 niflumic acid, and 5.0 4-amino pyridine at 20-21°C. Tetrodotoxin (TTX, Sigma 5 μmol/L) was included in the perfusate to suppress the inward Na + current. Voltage clamp was achieved using whole cell ruptured patch technique using an Axoclamp 2A amplifier (Axon Instruments, Foster City, CA, USA) operated in switch clamp mode. Pipette resistance was 7-10 MΩ. The pipette solution contained (mmol/L): 20 KCl, 100 K aspartate, 20 tetraethylammonium chloride, 10 HEPES, 4.5 MgCl 2 , calculated free [Mg 2+ ] ∼ 0.9 mmol/L; 4 Na 2 ATP, 1 Na 2 Creatine phosphate (free Na + = 10 mM), 0.1 EGTA, pH 7.25 with KOH. No correction for liquid-junction potentials was applied, the small DC offset observed in Krebs-Henseleit solution was nulled prior to patching on to the cell. Cytosolic loading of Fura-2 was achieved by incubating cardiomyocytes with 5 μmol/L Fura-2-AM at room temperature for 12 min. Cardiomyocytes were voltage clamped at − 80 mV and the voltage stepped to − 40 mV (50 ms) to inactivate the remaining inward Na + current, stepping to 0 mV (150 ms) before returning to − 80 mV.
E-C coupling studies at a range of SR Ca 2+ loads
The relationship between SR Ca 2+ content and Ca 2+ transient amplitude was investigated by superfusing cardiomyocytes for set periods of time with thapsigargin (5 μmol/L). This achieved a decrease in Ca 2+ transient amplitude and SR Ca 2+ content as a result of progressive SERCA2a inhibition. Complete inhibition of the SR was achieved after 100 s perfusion with thapsigargin; rapidly switching to 10 mmol/L caffeine did not generate a Ca 2+ -release or I NCX . Shorter periods of thapsigargin containing perfusion medium achieved intermediate caffeine responses representing intermediate SR Ca 2+ contents. Separate groups of cells were exposed to 40 s and 80 s periods of perfusion with thapsigargin, Ca 2+ transient amplitude was measured from the last 4 transients before caffeine application. SR Ca 2+ content was increased by using a voltage-clamp protocol where a holding potential of −50 mV was used. Measurements of L-type Ca 2+ channel current amplitude and the calculation of the integral of this current was used to verify that none of the above protocols caused a significant change in either of these parameters.
Ca 2+ spark and wave measurements in permeabilised cardiomyocytes
Isolated rabbit cardiomyocytes were superfused with a mock intracellular solution and permeabilised using β-escin (Sigma) as detailed previously [6] . 10 μmol/L Fluo-3 was excited at 488 nm (Kr laser) and measured N 515 nm using epifluorescence optics of an inverted microscope with a 60×/1.2 NA water-immersion objective lens. Fluorescence was acquired in line-scan mode at 2 ms/line; pixel dimension was 0.29 μm (512 pixels/scan; zoom = 1.4). The scanning laser line was oriented parallel with the long axis of the cell and placed approximately equidistant between the outer edge of the cell and the nucleus/nuclei, to ensure the nuclear area was not included in the scan line. To enable this trace to be converted to [Ca 2+ ] a series of calibration solutions were used at the end of each Ca 2+ spark measurement period incorporating 10 mmol/L EGTA as previously described [8] . In all experiments concerning Ca 2+ sparks, the [Ca 2+ ] in the test solution was 145-160 nmol/L. Ca 2+ sparks recorded in Fluo-3 containing solutions were quantified using an automatic detection and measurement algorithm adapted from a previously published method [8] . All Ca 2+ spark and wave measurements were made within 2-3 min of cell permeabilisation.
FK-506 binding protein (FKBP12.6) over-expression within rabbit cardiomyocytes
Recombinant adenoviruses were generated as previously described using cDNA encoding the full open reading frame of the human FKBP12.6 gene [9] . Two populations of adenovirus transfected cardiomyocytes were produced (i) overexpressing FKBP12.6 (Ad-FKBP12.6) and (ii) expressing βgalactosidase as control (Ad-LacZ). Infected cardiomyocytes were washed and subsequently cultured in supplemented M199 medium (Sigma) for 24 h. Verification of transgene expression and virus transfection efficiency has been detailed elsewhere [9] . Previous measurements suggest that the level of FKBP12.6 over-expression was approximately 6-fold that of control cells [9] .
Measurements of SERCA and RyR2 characteristics
Cardiomyocytes in suspension (∼ 2 × 10 5 cells/ml) were permeabilised by 0.1 mg/ml β-escin (Sigma), placed in a cuvette and stirred to maintain them in suspension (20-22°C). Fura-2 (10 μmol/L, Molecular Probes) was used to monitor the [Ca 2+ ] within the cuvette using a dual-wavelength spectrophotometer (Cairn Research Ltd). Oxalate (10 mmol/L Sigma) was added to maintain low and constant levels of intra-SR [Ca 2+ ]. This preparation was used to assess SERCA and RyR2 activities as described in Results.
Statistics
Data were expressed as mean ± SEM. For ionic currents, intracellular [Ca 2+ ] and Ca 2+ spark variables, comparisons were performed by using the paired Students' t-test and differences were considered significant when P b 0.05. ANOVA statistics with a Tukey post-test were used in cases of multiple comparisons.
Results
Measurements of intracellular [Ca 2+ ] in voltageclamped rabbit cardiomyocytes
In paired measurements, the Ca 2+ transient amplitude fell to 83 ± 7% (n = 13, P b 0.05) of control when perfused with 1 μmol/L K201 ( Fig. 1A (iii) and C(i)). The decay of the transient was fitted to a mono exponential. K201 (1 μmol/L) caused a small but significant decrease in the rate constant for decay (2.29 ± 0.17 s − 1 vs. 2.17 ± 0.15 s − 1 ; control vs. K201, P b 0.01). When perfused with 3 μmol/L K201 Ca 2+ transient amplitude was reduced to 60 ± 7% (n = 6, P b 0.05) of control ( Fig. 1A (iii) and C(i)). As illustrated in Fig. 1A (i) , I Ca,L amplitude was monitored by incorporating a pre-pulse to − 40 mV for 50 ms to inactivate the remaining inward I Na (in the presence of 5 μmol/L TTX). I Ca,L was not significantly different from control during perfusion with 1 μmol/L K201 97 ± 7% (n = 6), but perfusion with 3 μmol/L K201 resulted in reduction of I Ca,L to 66 ± 8.2% (n = 7, P b 0.05) of the control value ( Fig. 1A (ii) and 1C(ii)).
SR Ca 2+ content as assessed by rapid application of caffeine
When perfused with 1 μmol/L K201, the amplitude of the caffeine-induced Ca 2+ release was not significantly different (90 ± 7%, n = 10) from control ( Fig. 1B and D(i)). However, perfusion with 3 μmol/L K201 reduced the amplitude of the caffeine-induced Ca 2+ transient to 74 ± 8.9% of control (P b 0.05, n = 7; Fig. 1B and D(i)). As described previously [10] , the time integral of the I NCX can be used as a measure of the amount of Ca 2+ extruded by NCX during a caffeine application (an indicator of the SR Ca 2+ content). The mean integral of I NCX in the cells perfused with 1 μmol/L K201 was not significantly different from control (104 ± 10%, n = 4 cells). But in cells perfused with 3 μmol/L ( Fig. 1D (ii)), I NCX integral was reduced to 65 ± 6.6% (n = 5, P b 0.05) of control. This supports the conclusion that SR Ca 2+ content was significantly reduced by 3 μmol/L but not 1 μmol/L K201.
Sarcolemmal Ca 2+ efflux rates in rabbit cardiomyocytes
Sarcolemmal flux rates can be estimated from the time course of the decay of [Ca 2+ ] after rapid application of 10 mmol/L caffeine. As shown in Fig. 1B and D(i), [Ca 2+ ] decayed with a similar rate constant in cells perfused with both 1 μmol/L (101 ± 3%, n = 8 of control) and 3 μmol/L K201 (100 ± 6%, n = 7 of control) compared with control. This suggests that the rate of extrusion of Ca 2+ via NCX was not affected by K201.
The gain of E-C coupling
To determine the relationship between SR Ca 2+ -content and Ca 2+ transient amplitude, measurements were made at a range of SR loads. As shown in Fig. 1E , the plot of I NCX integral (SR Ca 2+ content) and Ca 2+ transient amplitude for the control group generated an approximately hyperbolic relationship. Analysis of I Ca,L indicated that there were no significant changes in the amplitude or time course of this current in the control and 1 μM K201 data-sets. Therefore, the hyperbolic relationship described by the control data represents the relationship between SR Ca 2+ content and the ability of I Ca,L to trigger Ca 2+ release from the SR; i.e. E-C coupling 'gain' [10, 11] . The data from the measurements made with 1 μM K201 lies on a gain curve to the right of the control group. K201 appears to decrease Ca 2+ transient amplitude by decreasing the fractional release of Ca 2+ from the SR.
For comparison, agents known to modulate Ca 2+ induced Ca 2+ release (CICR) from the SR were studied. Caffeine (0.5 mmol/L) and tetracaine (100 μmol/L) did not change the steady-state Ca 2+ transient amplitude compared to control, but significantly altered the SR Ca 2+ content. This result contrasts with the effects of K201, where decreased fractional SR Ca 2+ release manifests as a decrease in the Ca 2+ transient with no detectable changes in SR Ca 2+ content. The data for 3 μM K201 was plotted as a single point in Fig. 1E . The data lies to the right of the 1 μM K201 data suggesting reduced E-C coupling gain. However, direct comparisons cannot be made since this effect is accompanied by a reduction in I Ca,L .
Effects of K201 in intact cells during SR-mediated Ca 2+ overload
Voltage-clamped cardiomyocytes stimulated at 0.1 Hz were perfused at an extracellular [Ca 2+ ] of 8 mmol/L. The [Na + ] of the pipette solution was increased to 40 mmol/L. This consistently resulted in sufficient cellular Ca 2+ overload to generate regular, spontaneous Ca 2+ release from the SR during the diastolic period. Spontaneous Ca 2+ release frequency was monitored for a 50 s period before and after application of 1 μmol/L K201 ( Fig. 2A(ii) ). Control experiments were also performed with the use of the vehicle (DMSO, Fig. 2A(i) ). Ca 2+ wave frequency was significantly reduced during application of 1 μmol/L K201 ( Fig. 2A (ii) and B(i)) to 61.2 ± 9.67% (n = 5; P b 0.05) of the pre-K201 control period. The mean Ca 2+ transient amplitude over this 50 s period was maintained during the application of 1 μmol/L K201 despite this reduction Ca 2+ wave frequency ( Fig. 2B(ii) ).
Effects of K201 in permeabilised cells during SR-mediated Ca 2+ overload
Confocal microscopy was used to determine Ca 2+ wave characteristics in permeabilised ventricular cardiomyocytes perfused with a mock intracellular solution with 10 μmol/L Fluo-5F (free acid), 350 nmol/L [Ca 2+ ] [7] . Acute permeabilisation permitted functional bypass of sarcolemmal fluxes. The addition of 1 μmol/L K201 for 90 s significantly decreased Ca 2+ wave frequency to 77 ± 3.9%, (n = 6; P b 0.05) of control value ( Fig. 3A (i) and C(i)), while 3 μmol/L (n = 7) abolished Ca 2+ waves ( Fig. 3B (i) and C(i)). 1 μmol/L K201 significantly reduced mean Ca 2+ wave velocity (to 87 ± 4.2%, n = 5; P b 0.05, of control) while 3 μmol/L K201 reduced the velocity of the last wave (to 67.7 ± 6.5%, n = 6, P b 0.05, Fig. 3A(ii) , B(ii) and C(ii)). Although these changes in velocity and frequency were observed with 1 μmol/L K201, no change was observed in the mean Ca 2+ wave minimum or maximum [Ca 2+ ] (Fig. 3D (i) and (ii)). Neither the peak of the caffeine-induced Ca 2+ release during application of 1 μmol K201 nor the amplitude of the response was significantly altered when compared to control (Fig. 3D ). In 3 μmol K201, the amplitude of caffeineinduced Ca 2+ release was reduced compared to control, this contrasts to the substantial increase in the amplitude of caffeine-induced release observed in 100 μM tetracaine ( Fig. 3D (iii) TET).
Are the effects of K201 due to alteration in RyR2 Ca 2+ sensitivity?
The effects of K201 were compared with 100 μmol/L tetracaine, a drug known to reduce the Ca 2+ sensitivity of RyR2 without significant effects on SERCA [12] . As shown in Fig. 3E (i) and (ii), tetracaine abolishes Ca 2+ waves in a similar fashion to that observed with 3 μmol/L K201 ( Fig. 3B  (i) ). As reported [10] , the peak caffeine-induced Ca 2+ release (an indication of the SR Ca 2+ content) in tetracaine was higher than control ( Fig. 3E(i) ). This aspect of the response is different from the effects of K201; 3 μmol/L K201 caused a significant decrease in the amplitude of the caffeine-induced Ca 2+ release (Fig. 3D(iii) ). A decreased amplitude resulted from an increased minimum [Ca 2+ ] with no change in peak [Ca 2+ ] reached during application of caffeine. This effect was difficult to interpret since the caffeine-induced Ca 2+ releases were initiated from different minimum [Ca 2+ ] levels in control and during K201 application. To overcome this issue, the experiments were repeated using a higher concentration of EGTA (150 μmol/L) to abolish Ca 2+ waves but not caffeine-induced Ca 2+ release ( Fig. 3F(i) ). Under these conditions, the caffeine-induced Ca 2+ release in 1 μmol/L K201 was not significantly different, in 3 μmol/L K201 was 73 ± 10% of control (n = 9; P b 0.05). 100 μmol/L tetracaine resulted in an increase of Ca 2+ release (to 307 ± 17%) ( Fig. 3F ). This confirms the earlier observation that 3 μmol/L but not 1 μmol/L K201 reduces the SR Ca 2+ content.
3.8. The use of local application of caffeine in order to evoke Ca 2+ waves in 3 μmol/L K201 Potentially, 3 μmol/L K201 may abolish Ca 2+ waves by inhibiting the ability of local release to propagate throughout the cardiomyocyte. To test this hypothesis, caffeine (30 mmol/L) was applied at one end of the cardiomyocyte (Fig. 4A ) every 15 s to generate a series of local Ca 2+ releases. Under control conditions, each local Ca 2+ release propagates rapidly to the other end of the cardiomyocyte (Fig. 4B(i) ). Fluorescence signals from a 10 pixel band close to the area of local application of caffeine (L2) and at some distance from the point of initiation (L1) are shown in Fig. 4C(i) . These signals are shown during application of 3 μmol/L K201. Prior to the addition of K201, every evoked Ca 2+ wave in the control situation propagates to the other end of the cell (Fig. 3C(ii)a) . When similar procedures were performed during application of 3 μmol/L K201, local application of caffeine evoked a Ca 2+ release at adjacent sites, but only at intervals of ∼ 1 min and with a considerably lower propagation velocity (Fig. 4C(ii)b) . Attempts to initiate a propagating release at shorter intervals failed ( Fig. 4C (ii)c). 
The effect of 1 μmol/L K201 on Ca 2+ sparks
Ca 2+ sparks were examined in permeabilised cells perfused with 150-160 nmol/L [Ca 2+ ] and Fluo-3. The line-scan images obtained with and without 1 μmol/L K201 ( Fig. 5A(i) and (ii) and mean data (Fig. 5B) show that during application of 1 μmol/L K201 calcium spark duration (iii) and frequency (iv) were decreased to 82% and 63% of control respectively. 
The effects of K201 on SERCA activity
Measurements from the last Ca 2+ wave to occur in 3 μmol/L K201 showed a rate of decay that was significantly slower than control ( Fig. 6A(i) ) as was the case at 1 μmol/L K201 (Fig. 6A(ii) ). This suggests that the rate of Ca 2+ uptake by the SR was reduced.
In order to examine whether SERCA activity was affected by K201, oxalate-supported Ca 2+ uptake was measured in aggregates of permeabilised cardiomyocytes in the presence of 7 μmol/L ruthenium red. The rate of uptake of [Ca 2+ ] in the cuvette after addition of an aliquot of CaCl 2 was measured both before and after addition of K201. A quantitative description of SERCA activity was obtained by calculating the changes of total [Ca 2+ ] based on the known Ca 2+ -buffering capacity of the extracellular solution ( Fig. 6B(i) ). Differentiation of the total [Ca 2+ ] signal yields the rate of Ca 2+ uptake that can be plotted against the associated free [Ca 2+ ] (Fig. 6B  (ii) ). This relationship was fitted with a logistic curve to estimate the free [Ca 2+ ] that generated the half-maximal Ca 2+ uptake rate (K m ) and the value of V max . The mean data show that 1 and 3 μmol/L K201 increased the K m to 107 ± 2% (n = 6; P b 0.05) and 119 ± 6% (n =7; P b 0.05) respectively. The V max of SERCA was decreased at 1 and 3 μmol/L K201 to 88 ± 3% (n =6; P b 0.05) and 77 ± 3% respectively ( Fig. 5D(i) and (ii)).
The effects of K201 on RyR2 mediated Ca 2+ leak
RyR2-mediated Ca 2+ efflux in the absence of SERCA activity was observed in β-escin-permeabilised cardiomyocytes after Ca 2+ loading the SR. As shown in Fig. 6C(i) , the addition of 25 μmol/L thapsigargin and 20 mmol/L caffeine caused a rise of free [Ca 2+ ] within the cuvette as a result of Ca 2+ loss from the SR. The rate of Ca 2+ rise was substantially reduced by the prior addition of 7 μmol/L ruthenium red to block RyR2 (Fig. 6C(ii) ). The rate of rise of Ca 2+ was monitored in the absence and presence of 1 μmol/L and 3 μmol/L K201. As shown in Fig. 6C(ii) , K201 reduced the rate of Ca 2+ leak from the SR. The rate of rise of [Ca 2+ ] was measured at 500 nmol/L, as shown in Fig. 6D (iii) , the rate of Ca 2+ leak from the SR was reduced in a dose-dependent manner; 1 μmol/L K201 reduced the leak rate to 84± 5%, (n =9, P b 0.05); 3 μmol/L reduced the rate to 71 ± 6%, (n =9, P b 0.05). Ruthenium red (7 μmol/L) reduced the rate of Ca 2+ to 12 ± 2% (n =7, P b 0.01) of control. K201 had no effect on the residual Ca 2+ leak from the SR in the presence of ruthenium red (data not shown). These data support the contention that K201 inhibits RyR2 mediated Ca 2+ efflux from the SR.
The effect of K201 after FKBP12.6 over-expression
FKBP over-expression was used to increase substantially the fraction of RyR bound to FKBP12.6 ( Fig. 7) . Rabbit cardiomyocytes were permeabilised after 24 h of quiescent culture after transfection with a control virus (Ad-LacZ) or Ad-FKBP12.6. As shown in Fig. 7A and B , perfusion with shows Ca 2+ uptake data from aggregates of oxalate-equilibrated permeabilised myocytes (1 × 10 6 /ml) after addition of an aliquot of Ca 2+ (free Ca 2+ shown in black). This can be converted to total Ca 2+ (grey). Panel (ii), differentiation of the total [Ca 2+ ] signal reveals the rate of Ca 2+ uptake that can be plotted against the associated free [Ca 2+ ] shown for both control (black) and 3 μmol/L K201 (grey). Panel C shows the protocol used to measure RyR2-mediated Ca 2+ leak from the SR in aggregates of oxalateequilibrated permeabilised myocytes (1 × 10 6 /ml). Sequential additions of Ca 2+ were used to provide a standardised load of SR Ca 2+ . SERCA inhibition and RyR2 activation was initiated by addition of 25 μmol/L thapsigargin and 20 mmol/L caffeine and the time course of the rise of [Ca 2+ ] within the cuvette reflects the Ca 2+ leak from the SR. As shown in panel C(ii), the rate of rise of Ca 2+ was reduced with 3 μmol/L K201 or 7 μmol/L ruthenium red (RuR). Panel D: shows mean ± SEM values of the data for: (i) K m and (ii) V max of SERCA and (iii) RyR2 mediated Ca 2+ leak. 400 nmol/L Ca 2+ caused regular Ca 2+ waves as indicated from the average Fluo-3 fluorescence from a 20 pixel segment of a line-scan confocal image. 3 μmol/L K201 abruptly inhibits Ca 2+ waves as previously observed in freshly dissociated cells (Fig. 3) . On FKBP12.6 over-expression, the frequency of Ca 2+ waves within the permeabilised cardiomyocyte was significantly lower than control, but K201 caused an inhibition of waves with a similar time course to control ( Fig. 3B and C) . This data indicates that FKBP12.6 over-expression does not decrease the sensitivity of the SR to the inhibitory action of K201.
Discussion
This is the first study comparing the effects of K201 on EC coupling in normal and Ca 2+ overloaded ventricular cardiomyocytes.
The effects of K201 on intact cardiomyocytes
Application of 1 μmol/L K201 resulted in a reduction in the amplitude of Ca 2+ transients with no change in SR Ca 2+ content or I Ca,L amplitude. This suggests that I Ca,L is less effective at evoking Ca 2+ release from the SR, i.e. K201 reduced the gain of EC-coupling thereby reducing the fraction of Ca 2+ recirculated through the SR. One possible mechanism for this effect is reduction of the Ca 2+ sensitivity of RyR2. However, as previous studies have shown, selective reduction of the Ca 2+ sensitivity of RyR2 increases the SR Ca 2+ content but does not affect the steady-state Ca 2+ transient amplitude [10] . Therefore if K201 acts on RyR2, it must also act in parallel to reduce the SR Ca 2+ content, an action consistent with the inhibition of SERCA observed. All of the effects of K201 were reversible, normal parameters were restored after 2-3 min after return to control solution (see one-line supplement).
When normal cardiomyocytes were exposed to a high intracellular [Ca 2+ ], significant spontaneous diastolic Ca 2+ release occurred between the stimulated Ca 2+ transients. Application of 1 μmol/L K201 resulted in a reduction in the frequency of spontaneous Ca 2+ release, similar to that recently reported in unstimulated rat cardiomyocytes [13] . Under these conditions Ca 2+ transient amplitude was not reduced by K201. This may be due to a tendency to reduce SR Ca 2+ content as a result of SERCA inhibition [11] which is approximately balanced by a tendency to enhanced SR content due to inhibition of spontaneous SR Ca 2+ release [14] .
The effects of K201 on SR function in permeabilised cardiomyocytes
Previous studies have shown that reducing the sensitivity of RyR2 to Ca 2+ using the drug tetracaine results in an increase in SR Ca 2+ content [15] . This was confirmed in the present study. 100 μmol/L tetracaine abolished Ca 2+ waves with a similar time course to 3 μmol/L K201 and SR content was increased. But neither 1 nor 3 μmol/L K201 increased SR Ca 2+ content. Measurements in higher EGTA concentrations indicated that 3 μmol/L K201 reduced the SR Ca 2+ content to ∼ 72% of control. These data indicate a more complex mechanism for the action of K201 other than a reduced Ca 2+ sensitivity of RyR2 alone.
The rate of decline of the last Ca 2+ wave in both 1 and 3 μmol/L K201 was reduced suggesting that SERCA activity is directly affected by K201. This was confirmed by assessment of SERCA activity in oxalate-equilibrated permeabilised cardiomyocytes. A previous study using SR vesicles failed to observe an effect of 1 μmol/L K201 on SERCAmediated uptake [16] . The reason for this discrepancy is unknown, but the effect observed in this study was small (∼ 10%) and therefore may not have been detectable in SR vesicle preparations. Higher K201 concentrations (e.g. 3 μmol/L) caused a further inhibition (∼ 20%), but were not investigated in previous studies. RyR2-mediated Ca 2+ leak in oxalate-equilibrated cells was reduced by both 1 and 3 μmol/L K201 (Fig. 7C ). Together, these results show that K201 has an inhibitory effect on both RyR2 and SERCA activity. 
The effects of K201 on Ca 2+ sparks in permeabilised cardiomyocytes
Permeabilised cardiomyocytes were used to examine SR function directly. Under these circumstances, single cardiomyocytes can be superfused with a standardized [Ca 2+ ], [Mg 2+ ], pH, ATP and creatine phosphate concentration. 1 μmol/L K201 significantly reduced the frequency and amplitude of Ca 2+ spark characteristics, an effect consistent with actions on both RyR2 and SERCA [12] .
The effects of K201 on Ca 2+ waves in permeabilised cardiomyocytes
1 μmol/L K201 significantly reduced the frequency and velocity of Ca 2+ waves despite no significant change in SR Ca 2+ content. Reduced velocity and frequency is consistent with a reduced Ca 2+ sensitivity of RyR2 [17] . Moreover, this effect cannot be attributable to SERCA inhibition since a small degree of inhibition would be expected to have limited effects on Ca 2+ wave characteristics [18, 19] . Spontaneous Ca 2+ waves were abolished with 3 μmol/L K201 in the steady state, but local Ca 2+ release elicited by caffeine resulted in a propagated Ca 2+ wave at reduced frequency and velocity compared with control. These effects also cannot be explained by inhibition of SERCA alone since this would be expected to reduced Ca 2+ wave frequency not abolish waves completely [18, 20] . Since Ca 2+ sparks are still evident in 3 μmol/L K201, the absence of Ca 2+ waves could therefore be due to reduced sensitivity of the RyR2 preventing Ca 2+ release propagating throughout the cell. The larger Ca 2+ release caused by local application of caffeine is sufficient to trigger a propagated Ca 2+ wave. The increased time required between release events suggests that a longer time is required to re-establish the SR Ca 2+ content sufficient for a wave.
4.5.
Are the RyR2 mediated effects due to alteration of FKBP12.6 binding?
Whilst the effects of SERCA by K201 reported in this study are novel, the effects of K201 on RyR2 in isolated SR vesicle and lipid bilayer experiments have been reported previously [2] . A recent report has shown a similar effect of K201 on isoprenaline-induced transient inward currents (i ti ) and spontaneous Ca 2+ transients in mouse hearts with transgenically reduced FKBP12.6 expression [21] . Furthermore, K201 was ineffective on hearts from FKBP12.6 knockout mice. Taken together the data indicated that K201 acts by restoring FKBP12.6/RyR2 interaction thereby reducing the sensitivity of RyR2 to Ca 2+ . For this explanation to apply to the current study, the stoichiometry of FKBP12.6 to RyR2 would have to be less than maximal in isolated rabbit cardiomyocytes. To increase the FKBP12.6:RyR2 stoichiometry, FKBP12.6 concentration in the cell was increased by 5-6 fold using an adenoviral transfection system [8] . This has been shown to alter the characteristics of both Ca 2+ waves and sparks [8] . Despite this level of FKBP12.6, 3 μmol/L K201 was still able to suppress Ca 2+ waves to a similar degree to control cardiomyocytes while 1 μmol/L K201 had similar effects in all experimental groups (data not shown). The similarities of the response of K201, despite markedly different levels of FKBP12.6, suggest that the sensitivity of RyR2 to K201 is unaffected by increases in cytoplasmic FKBP12.6 above control levels.
In summary, this study has shown that 1 μmol/L K201 inhibited both RyR2 and SERCA activity without affecting sarcolemmal Ca 2+ influx or efflux via the L-type Ca 2+ channel or NCX activity respectively. Abnormal diastolic Ca 2+ leak, in the form of spontaneous Ca 2+ waves, was suppressed without alteration of SR Ca 2+ content. Evidence of the inhibition of Ca 2+ influx (via the L-type Ca 2+ channel) and a reduction in SR Ca 2+ content was only evident at a higher concentration of K201 (3 μmol/L) and was accompanied by a more profound inhibition of SERCA-and RyR2mediated Ca 2+ flux. It is therefore possible that the cellular basis for the anti-arrhythmic effect of K201 demonstrated in previous studies is via the drug's ability to affect multiple components of EC-coupling.
